Expert Insights on the Use of Oral JAK Inhibitors for Atopic Dermatitis: Raising the Bar for Standard of Care

home / between-the-lines / expert-insights-on-the-use-of-oral-jak-inhibitor-for-atopic-dermatitis-raising-the-bar-for

Experts discuss the results of multiple studies analyzing the incident rates and safety of Janus Kinase (JAK) inhibitors in the treatment of atopic dermatitis (AD).

© 2024 MJH Life Sciences

All rights reserved.